DK1140149T3 - Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation...... - Google Patents

Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......

Info

Publication number
DK1140149T3
DK1140149T3 DK99965579T DK99965579T DK1140149T3 DK 1140149 T3 DK1140149 T3 DK 1140149T3 DK 99965579 T DK99965579 T DK 99965579T DK 99965579 T DK99965579 T DK 99965579T DK 1140149 T3 DK1140149 T3 DK 1140149T3
Authority
DK
Denmark
Prior art keywords
growth hormone
antibalstic
transplant
therapies
restore
Prior art date
Application number
DK99965579T
Other languages
Danish (da)
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1140149T3 publication Critical patent/DK1140149T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99965579T 1998-12-30 1999-12-30 Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation...... DK1140149T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (de) 1998-12-30 1998-12-30 Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
DK1140149T3 true DK1140149T3 (da) 2007-02-19

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99965579T DK1140149T3 (da) 1998-12-30 1999-12-30 Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......

Country Status (15)

Country Link
US (1) US20060029581A1 (de)
EP (3) EP1016413A1 (de)
JP (1) JP4808316B2 (de)
AT (1) ATE342064T1 (de)
AU (2) AU772222B2 (de)
BR (1) BR9916726A (de)
CA (1) CA2354194A1 (de)
CY (1) CY1107603T1 (de)
DE (1) DE69933581T2 (de)
DK (1) DK1140149T3 (de)
ES (1) ES2275359T3 (de)
IL (2) IL143994A0 (de)
PT (1) PT1140149E (de)
SI (1) SI1140149T1 (de)
WO (1) WO2000040260A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2409197A1 (en) * 2000-06-07 2001-12-13 Applied Research Systems Ars Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
IL154159A0 (en) 2000-08-01 2003-07-31 Yissum Res Dev Co Directed differentiation of ebryonic cells
US6987102B2 (en) * 2001-07-31 2006-01-17 Anormed, Inc. Methods to mobilize progenitor/stem cells
WO2005032572A2 (en) * 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
CN103520735B (zh) * 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
CN107056929A (zh) * 2009-12-21 2017-08-18 Ambrx 公司 经过修饰的猪促生长素多肽和其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (de) * 1992-03-30 1993-10-06 Schering-Plough In-vitro-Erzeugung von menschlichen dendritischen Zellen
ATE213952T1 (de) * 1993-06-15 2002-03-15 British Biotech Pharm Freisetzung und mobilisierung hämatopoietischer zellen
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
US5650299A (en) * 1993-10-06 1997-07-22 The University Of Florida Cells producing stem cell proliferation factor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
US6103694A (en) * 1995-07-21 2000-08-15 The United States Of America As Represented By The Department Of Health And Human Services Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
JP2000503542A (ja) * 1996-01-16 2000-03-28 デピュイ オーソピーディック,インコーポレイテッド 造血及び非造血組織からの前駆細胞の分離及び in vivo 骨及び軟骨再生におけるそれらの使用
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DK1016414T3 (da) * 1998-12-17 2005-01-17 Applied Research Systems Humant væksthormon til stimulering af hæmatopoise og immunkonstitution efter transplantation med hæmatopoietiske stamceller i mennesker
CA2409197A1 (en) * 2000-06-07 2001-12-13 Applied Research Systems Ars Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
AU2103900A (en) 2000-07-24
IL143994A (en) 2009-06-15
CY1107603T1 (el) 2013-03-13
EP1140149A1 (de) 2001-10-10
WO2000040260A1 (en) 2000-07-13
ES2275359T3 (es) 2007-06-01
IL143994A0 (en) 2002-04-21
JP2002534393A (ja) 2002-10-15
EP1016413A1 (de) 2000-07-05
AU772222B2 (en) 2004-04-22
US20060029581A1 (en) 2006-02-09
ATE342064T1 (de) 2006-11-15
CA2354194A1 (en) 2000-07-13
PT1140149E (pt) 2007-01-31
DE69933581T2 (de) 2007-06-21
EP1779865A1 (de) 2007-05-02
AU2004203355B2 (en) 2007-05-17
EP1140149B1 (de) 2006-10-11
BR9916726A (pt) 2001-09-11
DE69933581D1 (de) 2006-11-23
AU2004203355A1 (en) 2004-08-19
JP4808316B2 (ja) 2011-11-02
SI1140149T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
Roux et al. Immunosuppressive mesenchymal stromal cells derived from human-induced pluripotent stem cells induce human regulatory T cells in vitro and in vivo
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
DK1526172T3 (da) Fremgangsmåde til replikation af influenzavira i cellekultur og ved fremgangsmåden opnåelige influenzavira
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
ATE514772T1 (de) Multipotente erwachsene stammzellen und verfahren zu deren isolierung
HUP0303930A2 (hu) Eljárás szervátültetési tolerancia indukálására és hemoglobinopátiák korrekciójára
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
WO2006047743A3 (en) Swine multipotent adult progenitor cells
WO2000001231A8 (en) Improved methods for storing neural cells
FI890821A (fi) Menetelmä kudossiirtoon soveltuvien, in vitro-viljeltyjen epiteelikalvojen säilyttämiseksi
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
ATE417655T1 (de) Teilbares snowboard mit bindungs- und verbindungssystem
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
Najar et al. Foreskin as a source of immunotherapeutic mesenchymal stromal cells
MXPA02003732A (es) Preparacion y seleccion de celulas donadoras para transplante nuclear.
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
WO1993009234A3 (en) Suppressor and progenitor cells
DE69434968D1 (de) Tiermodell für hepatitis-virus infektion
SG146623A1 (en) Rodent expression systems utilising polyoma virus and epstein barr virus sequences
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
WO2005032463A3 (en) Educated nkt cells and their uses in the treatment of immune-related disorders
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2003100010A3 (en) Cytokine-free growth and maintenance of progenitor cells